Long-term conditions panel excludes pharmacy
A multi-professional advisory panel that will advise the Government on how to implement the long-term
conditions national service framework was announced earlier this week by health minister Liam Byrne. However, the panel does not have pharmacy representation.
Robert Clayton, lead for long-term conditions and public health at the
Royal Pharmaceutical Society, said: “The Society very much applauds
the appointment of the advisory panel and has been working closely with
the Department of Health on ways of improving the management of long-term
conditions. The Society does however feel strongly that a pharmacist
should be present on the panel given the important contribution that
pharmacists are already making and will make to the delivery of the long-term
conditions agenda.”
The advisory panel will be chaired by Kathryn Hudson, the Department
of Health’s national clinical director for social care, and Ian
Philp, national clinical director for older people and neurological conditions,
and will have 15 additional members.
These members include a chief executive of a primary care trust, a speech
and language therapist, a GP, a physiotherapist, an occupational therapist,
a nursing policy adviser and consultants in neurology and rehabilitation
as well as directors of social services and specialist commissioning. |
The
Pharmaceutical Journal
Acrobat
Reader